der Neurologischen Klinik am Universitätsklinikum Heidelberg
Thank you very much for your interest in the neurooncology program of the Neurological Clinic at the Heidelberg University Hospital. Every year, the Neurooncology Program provides consultations to more than 4.000 patients and treats more than 1.500 patients with tumors of the nervous system. Furthermore, the program is extremely productive and the huge number of high-level publications not only position several of the senior investigators amongst the top scientists in their field, but also ensures development of junior researchers and allows for successful tenure paths.The year 2019 was dominated by structural developments in our neurooncology activities:
An outstanding event in the first half of the year was the approval of the first Collaborative Research Center 1389 - UNDERSTANDING AND TARGETING RESISTANCE IN GLIOBLASTOMA, coordinated by the Neurological Clinic. The spokesman of the CRC, which is funded with around 11 million euros, is Prof. Dr. Wolfgang Wick. co-spokepersons are Prof. Dr. Stefan Pister and Prof. Dr. Michael Platten. In addition to the DKFZ, the project partner is the Mannheim Medical Faculty of Heidelberg University. The CRC 1389, which connects many groups from our clinic, other departments, the DKFZ and the Mannheim location, deals with understanding and overcoming resistance in patients with glioblastomas. The CRC is innovation, strong structural bonds within a broad intellectual frame and a triggered by the strong vision that glioblastoma is treatable. The UNITEGLIOBLASTOMA abbreviated initiative, as a structural element of our clinic, ensures a further profile formation.
We successfully applied for the Else Kröner-Fresenius-Foundation funded Heidelberg Research College for Neurooncology. It is a colaborative Research College between the Neuroradiology, Neurooncologiy, Pediatric Oncologie (KiTZ Hopp Children's Cancer Center Heidelberg), Neuropathology und Radiation Therapy departments at the Heidelberg University Hospital. In addition to the speaker Wolfgang Wick, co-applicants are Professors Stefan Pfister, Martin Bendszus, Andreas von Deimling, Jürgen Debus and Sevin Turcan. With a total of 1 million euros, six fellows are funded as Clinician Scientists over four years. The Research College serves as a nucleus for further developments of our structured, interdisciplinary dialogue, and for the promotion of outstanding young medical professionals.
The University Hospital Heidelberg and the University Medical Center Mannheim have been selected by the Hertie Foundation as one of six locations in the Hertie Network of Excellence in Clinical Neuroscience. With the newly initiated network, the Hertie Foundation supports clinical neurosciences with a total of five million euros nationwide. The Heidelberg/Mannheim location in the Hertie Network with spokesman Prof. Dr. Wolfgang Wick and co-spokesman Prof. Dr. Michael Platten, is funded with 660,000 euros for four scholarship holders. The clinics top up the funding up to the amount of 1 million euros, available for the sponsored scholarship holders. The Hertie Academy of Clinical Neuroscience developed by the Hertie Foundation with the centers is intended to provide excellent young researchers with key qualifications for the next career steps and promote scientific networking, for example through joint projects. Within the network, the Heidelberg/Mannheim location focuses on neurooncology projects.
Follow us on Twitter
Prof. Wolfgang Wick about our Twitter account Neurooncology_HD @HdNeurooncology